Search


Current filters:




Start a new search
Add filters:

Use filters to refine the search results.


Results 1-5 of 5
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
30-Jan-2017Thienopyrimidinone based sirtuin-2 (SIRT2)-selective inhibitors bind in the ligand induced 'selectivity pocket'.Sundriyal, S; Moniot, S; Mahmud, Z; Yao, S; Di Fruscia, P, et al
15-Aug-2016RNF168 cooperates with RNF8 to mediate FOXM1 ubiquitination and degradation in breast cancer epirubicin treatmentLam, EW; Kongsema, M; Zona, S; Karunarathna, U; Yao, S, et al
13-Mar-2018SUMOylation modulates FOXK2-mediated paclitaxel sensitivity in breast cancer cellsNestal de Moraes, G; Ji, Z; Lavender, F; Yao, S; Zona, S, et al
4-Apr-2016BRCA1 positively regulates FOXO3 expression by restricting FOXO3 gene methylation and epigenetic silencing through targeting EZH2 in breast cancerLam, EW; Gong, C; Yao, S; Gomes, AR; Cancer Research UK, et al
1-Jun-2018The FOXO3-FOXM1 Axis: a key cancer drug target and a modulator of cancer drug resistanceYao, S; Fan, YN; Lam, EW; Biotechnology and Biological Sciences Research Council (BBSRC); Imperial College Trust, et al